Stereotaxis Inc (STXS) - Total Liabilities
Based on the latest financial reports, Stereotaxis Inc (STXS) has total liabilities worth $34.05 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore STXS year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Stereotaxis Inc - Total Liabilities Trend (2000–2024)
This chart illustrates how Stereotaxis Inc's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Stereotaxis Inc to measure how efficiently the company converts operating cash flow to free cash.
Stereotaxis Inc Competitors by Total Liabilities
The table below lists competitors of Stereotaxis Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Digital Asset Acquisition Corp.
NASDAQ:DAAQ
|
USA | $6.97 Million |
|
SICHUAN ENG.INV.DEV.H YC1
F:84H
|
Germany | €3.81 Billion |
|
LGI Ltd
AU:LGI
|
Australia | AU$55.30 Million |
|
IKIO Lighting Limited
NSE:IKIO
|
India | Rs1.58 Billion |
|
HLB Pharmaceutical Co. Ltd
KQ:047920
|
Korea | ₩46.98 Billion |
|
Dynamix Corporation
NASDAQ:ETHM
|
USA | $17.60 Million |
|
Marblegate Acquisition Corp
NASDAQ:GATE
|
USA | $24.23 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Stereotaxis Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see STXS stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Stereotaxis Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Stereotaxis Inc (2000–2024)
The table below shows the annual total liabilities of Stereotaxis Inc from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $35.29 Million | +76.56% |
| 2023-12-31 | $19.99 Million | -6.96% |
| 2022-12-31 | $21.48 Million | -0.35% |
| 2021-12-31 | $21.56 Million | +41.59% |
| 2020-12-31 | $15.23 Million | +1.11% |
| 2019-12-31 | $15.06 Million | +33.95% |
| 2018-12-31 | $11.24 Million | -64.05% |
| 2017-12-31 | $31.27 Million | -14.31% |
| 2016-12-31 | $36.50 Million | -0.97% |
| 2015-12-31 | $36.85 Million | +1.16% |
| 2014-12-31 | $36.43 Million | -14.84% |
| 2013-12-31 | $42.78 Million | -16.05% |
| 2012-12-31 | $50.96 Million | -13.28% |
| 2011-12-31 | $58.76 Million | +6.28% |
| 2010-12-31 | $55.29 Million | +14.04% |
| 2009-12-31 | $48.48 Million | -11.32% |
| 2008-12-31 | $54.67 Million | +50.68% |
| 2007-12-31 | $36.28 Million | +48.08% |
| 2006-12-31 | $24.50 Million | +32.21% |
| 2005-12-31 | $18.53 Million | +44.86% |
| 2004-12-31 | $12.79 Million | +6.11% |
| 2003-12-31 | $12.06 Million | +35.26% |
| 2002-12-31 | $8.91 Million | +365.68% |
| 2000-12-31 | $1.91 Million | -- |
About Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more